Prior to FY22 results on February 23, Morgan Stanley forecasts proportional earnings (EBITDA) for Atlas Arteria of $6.3bn in FY22, a rise of 16% against FY21.

The Equal-weight rating and $6.88 target are unchanged. Industry View: Cautious.

Sector: Transportation.

Target price is $6.88.Current Price is $6.99. Difference: ($0.11) - (brackets indicate current price is over target). If ALX meets the Morgan Stanley target it will return approximately -2% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2023 Acquisdata Pty Ltd., source FN Arena